The Prime Minister’s Prize for Innovation went to WEHI’s venetoclax team, an anti-cancer drug that was nearly three decades in the making and specifically impacts the BCL-2 protein. US researchers are trialing an immunotherapy that attacks two blood cancer cell targets, rather than the conventional one, the design aims to achieve a more robust defense. A UK researcher has discovered the mutant gene that is involved in driving the progression of a previously untreatable childhood brain cancer. What happens after the cancer treatment? Women experience several side-effects from cancer treatment, including early menopause. How do clinicians address these challenges? |
| | | Monday 14 October - Monday 21 October | | | The Age (Licensed by Copyright Agency) • Oct 20, 2019 17:38 | | | Usually bolted shut, the Australian Synchrotron is now open to all The doors to the Australian Synchrotron are usually bolted shut. But on Sunday, hundreds of budding researchers... in awe through the enormous facility – home to research in fields as diverse as cancer treatment and art history. The Synchrotron is an MCG- |
|
| | The Department of Health • Oct 15, 2019 21:6 | | | Address to Medicines Australia's PharmAus 2019 Read Minister Hunt's address to Medicines Australia's PharmAus 2019. Minister Hunt talks about the Australian Government's medicines... under the Medical Research Future Fund. We announced in the 2019 Budget a 10-year investment plan for the Medical Research Future Fund – so |
|
| | The Medical Republic • Oct 14, 2019 16:6 | | | Menopause symptoms after cancer – navigating the current treatment options Troublesome menopausal symptoms are common for women of all ages after cancer treatment, and the safe and effective management of these... Hickey, Head of the Gynaecology Research Centre at The University of Melbourne and The Royal Women’s Hospital, about current treatment |
|
|
|
|
|
|
